Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
OXSM - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
DYNLT3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WDR3 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AIMP2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
C10orf95 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GEO DataSets Gene Profile neighbors Chromosome neighbors
LOC101927137 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
OGFOD2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
COPA - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PMS2P9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GOLGB1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
EPHA2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CYB5R2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
PPP2R3A - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
FUT9 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
AP2B1 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
WBP1L - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
MRPS14 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
CREBL2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GRB2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
GCC2 - Melanoma cell line response to E2F-1 overexpression and doxorubicin treatment
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on